![Kai Lin Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kai Lin Liu
Chief Investment Officer bij Beijing Biostar Pharmaceuticals Co. Ltd.
Actieve functies van Kai Lin Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Chief Investment Officer | 01-07-2020 | - |
Bedrijfssecretaris | 01-09-2020 | - | |
Investor Relations Contact | - | - |
Loopbaan van Kai Lin Liu
Opleiding van Kai Lin Liu
Nankai University | Graduate Degree |
Statistieken
Internationaal
China | 3 |
Operationeel
Graduate Degree | 1 |
Chief Investment Officer | 1 |
Investor Relations Contact | 1 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Kai Lin Liu
- Ervaring